- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02607098
Understanding Adaptive Challenges Associated With Male-factor Infertility
February 28, 2017 updated by: Duke University
The purpose of this study is to understand the experience of men and their partners when diagnosed with male-factor infertility while trying to achieve a pregnancy and the skills they use to adapt to this diagnosis.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
24
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
England
-
Newcastle-upon-Tyne, England, United Kingdom
- Newcastle Fertility Centre
-
-
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
This study will recruit a convenience sample of 10 men and their partners seeking consultation from a fertility urologist following the detection of male-factor infertility.
Description
Inclusion criteria:
Men:
- in a partnered relationship with a female
- have been trying without success to conceive a pregnancy
- have been referred due to suspected or diagnosed male-factor infertility
- have the ability to read and write English
Female Partner:
- 18 to 40 years of age
- ability to read and write English
Exclusion criteria:
- living children, either biological or adoptive
- history of vasectomy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Males diagnosed with male-factor infertility
This study will recruit a convenience sample of 10 men and their partners seeking consultation from a fertility urologist following the detection of male-factor infertility.
|
|
Female partners
This study will recruit a convenience sample of 10 men and their partners seeking consultation from a fertility urologist following the detection of male-factor infertility.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Feasibility, as measured by the percentage of eligible subjects agreed to participate
Time Frame: 6 months
|
6 months
|
|
Feasibility, as measured by retention percentage
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in level of global infertility stress, as measured by questionnaire
Time Frame: Baseline, 6 months
|
Baseline, 6 months
|
|
|
Change in quality of life, as measured by questionnaire
Time Frame: Baseline, 6 months
|
Baseline, 6 months
|
|
|
Change in level of global infertility stress, as measured by questionnaire
Time Frame: Pre and post significant event, up to 7 months
|
The investigators will determine the change in pre and post significant event (when reported, such as new diagnosis, IVF/ICSI, discontinuation of treatment) level of global infertility stress in both the man and his partner.
|
Pre and post significant event, up to 7 months
|
|
Change in quality of life, as measured by questionnaire
Time Frame: Pre and post significant event, up to 7 months
|
The investigators will determine the change in pre and post significant event (when reported, such as new diagnosis, IVF/ICSI, discontinuation of treatment) level of quality of life in both the man and his partner.
|
Pre and post significant event, up to 7 months
|
|
Concordance between men and partners with respect to levels of global infertility stress, as measured by questionnaire
Time Frame: 3 months
|
3 months
|
|
|
Concordance between men and partners with respect to quality of life, as measured by questionnaire
Time Frame: 3 months
|
3 months
|
|
|
Concordance between men and partners with respect to levels of global infertility stress, as measured by questionnaire
Time Frame: 6 months
|
6 months
|
|
|
Concordance between men and partners with respect to quality of life, as measured by questionnaire
Time Frame: 6 months
|
6 months
|
|
|
Feasibility, as measured by percentage of participants who used text messaging to complete their study questionnaires
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Eleanor Stevenson, Ph.D., Duke University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2015
Primary Completion (Actual)
November 1, 2016
Study Completion (Actual)
November 1, 2016
Study Registration Dates
First Submitted
November 13, 2015
First Submitted That Met QC Criteria
November 13, 2015
First Posted (Estimate)
November 17, 2015
Study Record Updates
Last Update Posted (Actual)
March 1, 2017
Last Update Submitted That Met QC Criteria
February 28, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00065075
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Male-factor Infertility
-
BiocoatCompletedMale Factor InfertilityUnited States
-
Rabin Medical CenterUnknownUnexplained Infertility | Mild Male FactorIsrael
-
Assiut UniversityUnknownIn Vitro Fertilization | Male Factor InfertilityEgypt
-
UConn HealthThe Center for Advanced Reproductive Services, P.C.RecruitingInfertility | Male Factor InfertilityUnited States
-
Umraniye Education and Research HospitalRecruitingMale Factor InfertilityTurkey
-
Rambam Health Care CampusUnknownEndometriosis | PCOS | Male Factor Infertility | Advised Maternal Age
-
Galaxy Pharma (Pvt) LimitedOva IVF & Reproductive Health Clinics, KarachiRecruitingSecondary Infertility | Primary Infertility | Low Responders | Mild to Moderate Male Factor InfertilityPakistan
-
Femasys Inc.Completed
-
Sahlgrenska University Hospital, SwedenUniversity Hospital Tuebingen; University of BelgradeCompletedCervical Cancer | Absolute Uterine Factor InfertilitySweden
-
Cairo UniversityShaimaa Mostafa; Yasmin Zakaria; Ibrahim Fawzy; Mona Aboulghar; Mona FouadTerminated